TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5446.31M
Enterprise Value 3327.97M
Trailing P/E N/A
Forward P/E 1-3.54
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2,928.94
Price/Book (mrq)4.08
Enterprise Value/Revenue 32,152.31
Enterprise Value/EBITDA 6-2.17

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-99,280.58%

Management Effectiveness

Return on Assets (ttm)-87.49%
Return on Equity (ttm)-198.93%

Income Statement

Revenue (ttm)152.38k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)152.38k
EBITDA -151.2M
Net Income Avi to Common (ttm)-150.48M
Diluted EPS (ttm)-2.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)97.74M
Total Cash Per Share (mrq)1.27
Total Debt (mrq)91k
Total Debt/Equity (mrq)0.13
Current Ratio (mrq)2.73
Book Value Per Share (mrq)1.33

Cash Flow Statement

Operating Cash Flow (ttm)-117.09M
Levered Free Cash Flow (ttm)-61.19M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.71
52-Week Change 3-38.82%
S&P500 52-Week Change 35.34%
52 Week High 317.35
52 Week Low 34.20
50-Day Moving Average 35.27
200-Day Moving Average 310.67

Share Statistics

Avg Vol (3 month) 31.66M
Avg Vol (10 day) 31.38M
Shares Outstanding 582.5M
Float 53.94M
% Held by Insiders 112.02%
% Held by Institutions 154.74%
Shares Short (Oct 31, 2018) 411.01M
Short Ratio (Oct 31, 2018) 47.61
Short % of Float (Oct 31, 2018) 416.69%
Short % of Shares Outstanding (Oct 31, 2018) 413.30%
Shares Short (prior month Sep 28, 2018) 410.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2100/5625
Last Split Date 3Apr 30, 2012